Trial
NCT06110195
Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
EMD Serono
Condition
Head and Neck Cancer
Intervention
Xevinapant
Why stopped
Drug no longer being developed by manufacturer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31